EdgarLookup

IOVANCE BIOTHERAPEUTICS, INC. — 10-Q Filings

54 10-Q filings on record

This page lists all 10-Q filings submitted to the SEC by IOVANCE BIOTHERAPEUTICS, INC. (IOVA), sorted by most recent first. Each row links to the full filing on EdgarLookup. IOVANCE BIOTHERAPEUTICS, INC. has filed 54 10-Q documents with the SEC since 2008. To view all SEC filings by IOVANCE BIOTHERAPEUTICS, INC., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 10-Q/A 144 3 3/A 4 4/A 424B3 424B5 5 8-A12B 8-A12B/A 8-A12G 8-K 8-K/A ARS CERTNAS CORRESP CT ORDER D DEF 14A DEF 14C DEFA14A EFFECT NT 10-K NT 10-Q POS AM PRE 14A PRE 14C PRER14A S-1 S-1/A S-3 S-3/A S-3ASR S-3MEF S-8 S-8 POS SB-2 SC 13D SC 13D/A SC 13G SC 13G/A SC 14F1 SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
10-Q 10-Q 0001104659-25-107470 Nov 6, 2025 Sep 30, 2025
10-Q 10-Q 0001558370-25-010807 Aug 7, 2025 Jun 30, 2025
10-Q 10-Q 0001558370-25-007009 May 8, 2025 Mar 31, 2025
10-Q 10-Q 0001558370-24-014905 Nov 7, 2024 Sep 30, 2024
10-Q 10-Q 0001558370-24-011641 Aug 8, 2024 Jun 30, 2024
10-Q 10-Q 0001558370-24-007646 May 9, 2024 Mar 31, 2024
10-Q 10-Q 0001558370-23-018029 Nov 7, 2023 Sep 30, 2023
10-Q 10-Q 0001558370-23-013988 Aug 8, 2023 Jun 30, 2023
10-Q 10-Q 0001558370-23-009134 May 10, 2023 Mar 31, 2023
10-Q 10-Q 0001558370-22-016295 Nov 3, 2022 Sep 30, 2022
10-Q 10-Q 0001558370-22-012263 Aug 4, 2022 Jun 30, 2022
10-Q 10-Q 0001558370-22-007449 May 5, 2022 Mar 31, 2022
10-Q 10-Q 0001558370-21-014670 Nov 4, 2021 Sep 30, 2021
10-Q 10-Q 0001558370-21-010617 Aug 5, 2021 Jun 30, 2021
10-Q 10-Q 0001558370-21-006301 May 6, 2021 Mar 31, 2021
10-Q 10-Q 0001558370-20-012946 Nov 5, 2020 Sep 30, 2020
10-Q FORM 10-Q 0001104659-20-091526 Aug 6, 2020 Jun 30, 2020
10-Q 10-Q 0001104659-20-056994 May 5, 2020 Mar 31, 2020
10-Q 10-Q 0001104659-19-059564 Nov 4, 2019 Sep 30, 2019
10-Q FORM 10-Q 0001144204-19-037248 Aug 1, 2019 Jun 30, 2019
10-Q FORM 10-Q 0001144204-19-024279 May 7, 2019 Mar 31, 2019
10-Q FORM 10-Q 0001144204-18-057663 Nov 6, 2018 Sep 30, 2018
10-Q FORM 10-Q 0001144204-18-042241 Aug 7, 2018 Jun 30, 2018
10-Q 10-Q 0001144204-18-026764 May 10, 2018 Mar 31, 2018
10-Q 10-Q 0001144204-17-055799 Nov 2, 2017 Sep 30, 2017
10-Q FORM 10-Q 0001144204-17-040380 Aug 3, 2017 Jun 30, 2017
10-Q 10-Q 0001144204-17-024234 May 3, 2017 Mar 31, 2017
10-Q FORM 10-Q 0001144204-16-131686 Nov 4, 2016 Sep 30, 2016
10-Q 10-Q 0001144204-16-117596 Aug 9, 2016 Jun 30, 2016
10-Q 10-Q 0001144204-16-099858 May 9, 2016 Mar 31, 2016
10-Q FORM 10-Q 0001144204-15-063327 Nov 6, 2015 Sep 30, 2015
10-Q 10-Q 0001144204-15-047780 Aug 10, 2015 Jun 30, 2015
10-Q FORM 10-Q 0001144204-15-029130 May 11, 2015 Mar 31, 2015
10-Q LION BIOTECHNOLOGIES, INC. QUARTERLY REPORT 0001513160-14-000060 Nov 13, 2014 Sep 30, 2014
10-Q LION BIOTECHNOLOGIES QUARTERLY REPORT 0001513160-14-000039 Aug 8, 2014 Jun 30, 2014
10-Q QUARTERLY REPORT 0001354488-14-002559 May 14, 2014 Mar 31, 2014
10-Q LION BIOTECHNOLOGIES QUARTERLY REPORT 0001513160-13-000069 Nov 14, 2013 Sep 30, 2013
10-Q LION BIOTECHNOLOGIES FORM 10-Q 0001513160-13-000062 Oct 23, 2013 Jun 30, 2013
10-Q LION BIOTECHNOLOGIES FORM 10-Q 0001513160-13-000061 Oct 23, 2013 Mar 31, 2013
10-Q GENESIS BIOPHARMA FORM 10-Q 0001513160-13-000022 Jan 25, 2013 Sep 30, 2012
10-Q GENESIS BIOPHARMA FORM 10-Q 0001513160-12-000056 Aug 14, 2012 Jun 30, 2012
10-Q GENESIS BIOPHARMA FORM 10-Q 0001513160-12-000038 May 15, 2012 Mar 31, 2012
10-Q FORM 10-Q 0001144204-11-066214 Nov 21, 2011 Sep 30, 2011
10-Q QUARTERLY REPORT 0001144204-11-049087 Aug 22, 2011 Jun 30, 2011
10-Q — 0001144204-11-031493 May 20, 2011 Mar 31, 2011
10-Q — 0001144204-10-061551 Nov 17, 2010 Sep 30, 2010
10-Q — 0001144204-10-044769 Aug 16, 2010 Jun 30, 2010
10-Q — 0001144204-10-027608 May 14, 2010 Mar 31, 2010
10-Q QTRLY REPORT FOR THE QTR ENDED 9-30-09 0001165527-09-000784 Oct 23, 2009 Sep 30, 2009
10-Q QTRLY REPORT FOR THE QTR ENDED 6-30-09 0001165527-09-000493 Jul 27, 2009 Jun 30, 2009